United States Breast Cancer Diagnostic Devices Market to Cross $ 2 billion by 2020: Pharmaion Report

02 Feb, 2016, 10:30 ET from Pharmaion

BURNABY, Canada, February 2, 2016 /PRNewswire/ --

Increasing awareness about the benefits of early diagnosis and growing technological advancements to drive United States breast cancer diagnostics devices market through 2020 

According to Pharmaion report, "United States Breast Cancer Diagnostics Devices Market Opportunities, 2010 - 2020", breast cancer diagnostic devices market in the United States is projected to cross US$ 2 billion by 2020. Growing prevalence of breast cancer, ageing demographics and rising awareness about breast cancer and early diagnosis are projected to propel growth in the United States breast cancer diagnostic devices through 2020. Moreover, favorable reimbursement scenario in the country is encouraging citizens to visit diagnostic laboratories and hospitals for breast cancer screening, consequently aiding growth of the breast cancer diagnostic devices market in the United States.

High prevalence of breast cancer and associated mortality is also motivating the government to take initiatives to improve breast cancer survival rate. Centers for Disease Control and Prevention (CDC) initiated National Breast and Cervical Cancer Early Detection Program (NBCCEDP) to provide timely breast and cervical cancer screening, and breast cancer services to low income, uninsured and undeserved women in the United States. Moreover, various breast cancer associated non-profit organizations in the United States organize "Breast Cancer Month" each year in November to increase awareness about the disease and promote the need for early diagnosis.

In terms of test type, the United States breast cancer diagnostic devices market has been segmented into three categories - screening and diagnostic imaging devices, lab diagnostic devices, and others. Screening and diagnostic imaging devices dominated the United States breast cancer diagnostic devices market in 2014 and the segment is anticipated to continue its dominance through 2020. South region, followed by Midwest, are the leading regional markets for breast cancer diagnostic devices in the United States. Few of the leading companies operating in the United States breast cancer diagnostic devices market include Hologic Inc., Siemens Healthcare Diagnostics, Inc., Devicor Medical Products and GE Healthcare, among others.

"United States breast cancer diagnostic devices market is forecast to witness promising growth in the next five years, due to increasing technological advancements, availability of effective and efficient breast cancer imaging and diagnostic devices such as Contrast-enhanced Mammography, Novel Breast Cancer Diagnostics Biomarkers, Vacuum-Assisted Biopsy, CAD for Mammography, etc., in the country. Moreover, economic stability of healthcare providers to purchase these expensive diagnostic devices is also fueling growth of breast cancer diagnostic devices market in the United States." said Ms. Pritpal Kaur, Consultant, with Pharmaion Consultants, a research based global management consulting firm focused on pharma and healthcare industry.

"United States Breast Cancer Diagnostics Devices Market Opportunities, 2010 - 2020" has analysed the potential of breast cancer diagnostic devices market in the United States and provides statistics and information on market sizes, shares and trends. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with essential drivers and key challenges faced by the United States breast cancer diagnostic devices market.

About Pharmaion: 

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, Pharmaion's clients lead rather than follow market trends. Pharmaion has developed a proprietary database which focuses on identifying the unexplored opportunities in Healthcare and Pharmaceutical industry.

Media Contact:
Karan Chechi
Research Director
Contact Phone- +1 646 862 0089
Email- sales@pharmaion.com


SOURCE Pharmaion